4 research outputs found

    Mortality risk factors among critically ill children with MIS-C in PICUs: a multicenter study

    No full text
    Background: This study evaluated of clinical characteristics, outcomes, and mortality risk factors of a severe multisystem inflammatory syndrome in children admitted to a the pediatric intensive care unit. Methods: A retrospective multicenter cohort study was conducted between March 2020 and April 2021 at 41 PICUs in Turkey. The study population comprised 322 children diagnosed with multisystem inflammatory syndrome. Results: The organ systems most commonly involved were the cardiovascular and hematological systems. Intravenous immunoglobulin was used in 294 (91.3%) patients and corticosteroids in 266 (82.6%). Seventy-five (23.3%) children received therapeutic plasma exchange treatment. Patients with a longer duration of the PICU stay had more frequent respiratory, hematological, or renal involvement, and also had higher D-dimer, CK-MB, and procalcitonin levels. A total of 16 patients died, with mortality higher in patients with renal, respiratory, or neurological involvement, with severe cardiac impairment or shock. The non-surviving group also had higher leukocyte counts, lactate and ferritin levels, and a need for mechanical ventilation. Conclusions: In cases of MIS-C, high levels of D-dimer and CK-MB are associated with a longer duration of PICU stay. Non-survival correlates with elevated leukocyte counts and lactate and ferritin levels. We were unable to show any positive effect of therapeutic plasma exchange therapy on mortality. Impact: MIS-C is a life-threatening condition.Patients need to be followed up in the intensive care unit.Early detection of factors associated with mortality can improve outcomes.Determining the factors associated with mortality and length of stay will help clinicians in patient management.High D-dimer and CK-MB levels were associated with longer PICU stay, and higher leukocyte counts, ferritin and lactate levels, and mechanical ventilation were associated with mortality in MIS-C patients.We were unable to show any positive effect of therapeutic plasma exchange therapy on mortality

    Microbial Energy Production

    No full text
    Today's increasing energy needs and the environmental damage of fossil fuels have prompted humankind to seek new and sustainable energy sources. Besides solar energy, seas, oceans, and wind energy, the metabolic pathways of energy formation in cells have opened the gates of new energy sources to us. Both cells and their enzymes can be used for production of renewable energy. These mechanical cells acting like live cells were called biological fuel cells. They can produce electricity using wastewater, biodegredable organic material, and/or direct organic chemicals such as glucose. Today, these devices are still being developed for increasing electric power and for different space applications by scientists. © 2018 Elsevier Inc. All rights reserved
    corecore